Aaron Mendelsohn

At Johns Hopkins, Aaron Mendelsohn is a lecturer in the MS in Biotechnology program. He is an epidemiologist specializing in pharmaceutical risk management, disease and drug-based registries, infectious disease epidemiology, patient preferences and patient-reported outcomes, and epidemiological methods. His research activities involve evaluating safety and effectiveness outcomes, and utilization patterns, for medicinal products real-world data, including claims data and electronic health records.

Mendelsohn earned his PhD in Epidemiology from the University of Pittsburgh. He received post-doctoral training in applied epidemiology through the Centers for Disease Control and Prevention’s Epidemic Intelligence Service where he was assigned to the U.S. Food and Drug Administration. There his primary responsibility was conducting active surveillance for adverse drug events through a representative network of emergency departments in the United States. His work at the FDA earned him the Agency’s Outstanding Service Award as part of the NSAID Scientific Review Team.

Mendelsohn has consulted for a variety of pharmaceutical and biotechnology companies and has delivered numerous webinars and training courses to regulators and international audiences on benefit-risk evaluation of medicinal products.